
    
      To improve the function and welfare of late stage solid cancer subjects by:

        -  enabling subjects to benefit from a potentially promising drug under development

        -  assessing initial evidence of improvement in Pain VAS score

        -  assessing initial improvement in Performance Status (PS)

        -  assessing improvement in oxygen saturation whenever it is feasible/ dyspnea measurement
           (Modified Borg Scale)
    
  